UniProt ID | SRSF6_HUMAN | |
---|---|---|
UniProt AC | Q13247 | |
Protein Name | Serine/arginine-rich splicing factor 6 | |
Gene Name | SRSF6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 344 | |
Subcellular Localization | Nucleus . Nucleus speckle . | |
Protein Description | Plays a role in constitutive splicing and modulates the selection of alternative splice sites. Plays a role in the alternative splicing of MAPT/Tau exon 10. Binds to alternative exons of TNC pre-mRNA and promotes the expression of alternatively spliced TNC. Plays a role in wound healing and in the regulation of keratinocyte differentiation and proliferation via its role in alternative splicing.. | |
Protein Sequence | MPRVYIGRLSYNVREKDIQRFFSGYGRLLEVDLKNGYGFVEFEDSRDADDAVYELNGKELCGERVIVEHARGPRRDRDGYSYGSRSGGGGYSSRRTSGRDKYGPPVRTEYRLIVENLSSRCSWQDLKDFMRQAGEVTYADAHKERTNEGVIEFRSYSDMKRALDKLDGTEINGRNIRLIEDKPRTSHRRSYSGSRSRSRSRRRSRSRSRRSSRSRSRSISKSRSRSRSRSKGRSRSRSKGRKSRSKSKSKPKSDRGSHSHSRSRSKDEYEKSRSRSRSRSPKENGKGDIKSKSRSRSQSRSNSPLPVPPSKARSVSPPPKRATSRSRSRSRSKSRSRSRSSSRD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | RVYIGRLSYNVREKD CEEEEEEEECCCHHH | 17.19 | 28555341 | |
23 | Phosphorylation | KDIQRFFSGYGRLLE HHHHHHHCCCCCEEE | 28.52 | 28152594 | |
25 | Phosphorylation | IQRFFSGYGRLLEVD HHHHHCCCCCEEEEE | 9.62 | 23186163 | |
37 | Phosphorylation | EVDLKNGYGFVEFED EEECCCCCEEEEEEC | 19.45 | 28152594 | |
45 | Phosphorylation | GFVEFEDSRDADDAV EEEEEECCCCCCCCE | 25.51 | 19664994 | |
53 | Phosphorylation | RDADDAVYELNGKEL CCCCCCEEEECCEEC | 19.20 | 28450419 | |
58 | Ubiquitination | AVYELNGKELCGERV CEEEECCEECCCCEE | 46.57 | 33845483 | |
58 | Acetylation | AVYELNGKELCGERV CEEEECCEECCCCEE | 46.57 | 26051181 | |
71 | Methylation | RVIVEHARGPRRDRD EEEEEECCCCCCCCC | 58.52 | - | |
80 | Phosphorylation | PRRDRDGYSYGSRSG CCCCCCCCCCCCCCC | 11.74 | 20068231 | |
81 | Phosphorylation | RRDRDGYSYGSRSGG CCCCCCCCCCCCCCC | 28.66 | 21712546 | |
82 | Phosphorylation | RDRDGYSYGSRSGGG CCCCCCCCCCCCCCC | 15.61 | 30576142 | |
84 | Phosphorylation | RDGYSYGSRSGGGGY CCCCCCCCCCCCCCC | 18.29 | 26055452 | |
85 | Methylation | DGYSYGSRSGGGGYS CCCCCCCCCCCCCCC | 34.65 | 80700761 | |
86 | Phosphorylation | GYSYGSRSGGGGYSS CCCCCCCCCCCCCCC | 43.41 | 25849741 | |
91 | Phosphorylation | SRSGGGGYSSRRTSG CCCCCCCCCCCCCCC | 13.52 | 20068231 | |
92 | Phosphorylation | RSGGGGYSSRRTSGR CCCCCCCCCCCCCCC | 22.20 | 26074081 | |
93 | Phosphorylation | SGGGGYSSRRTSGRD CCCCCCCCCCCCCCC | 19.80 | 26074081 | |
96 | Phosphorylation | GGYSSRRTSGRDKYG CCCCCCCCCCCCCCC | 34.13 | 27174698 | |
97 | Phosphorylation | GYSSRRTSGRDKYGP CCCCCCCCCCCCCCC | 29.98 | 29496963 | |
101 | Ubiquitination | RRTSGRDKYGPPVRT CCCCCCCCCCCCCCC | 51.23 | 23000965 | |
101 | 2-Hydroxyisobutyrylation | RRTSGRDKYGPPVRT CCCCCCCCCCCCCCC | 51.23 | - | |
101 | Acetylation | RRTSGRDKYGPPVRT CCCCCCCCCCCCCCC | 51.23 | 23749302 | |
102 | Phosphorylation | RTSGRDKYGPPVRTE CCCCCCCCCCCCCCC | 38.87 | 28152594 | |
108 | Phosphorylation | KYGPPVRTEYRLIVE CCCCCCCCCHHHHHH | 37.29 | 28152594 | |
110 | Phosphorylation | GPPVRTEYRLIVENL CCCCCCCHHHHHHCH | 15.31 | 28152594 | |
118 | Phosphorylation | RLIVENLSSRCSWQD HHHHHCHHHCCCHHH | 27.58 | 29255136 | |
119 | Phosphorylation | LIVENLSSRCSWQDL HHHHCHHHCCCHHHH | 40.24 | 19664994 | |
122 | Phosphorylation | ENLSSRCSWQDLKDF HCHHHCCCHHHHHHH | 27.02 | 25159151 | |
127 | Acetylation | RCSWQDLKDFMRQAG CCCHHHHHHHHHHCC | 58.15 | 26051181 | |
127 | Ubiquitination | RCSWQDLKDFMRQAG CCCHHHHHHHHHHCC | 58.15 | 21906983 | |
127 (in isoform 1) | Ubiquitination | - | 58.15 | 21890473 | |
127 (in isoform 3) | Ubiquitination | - | 58.15 | 21890473 | |
137 | Phosphorylation | MRQAGEVTYADAHKE HHHCCCCEEHHHHHH | 14.53 | 28152594 | |
138 | Phosphorylation | RQAGEVTYADAHKER HHCCCCEEHHHHHHH | 13.99 | 28152594 | |
143 | Acetylation | VTYADAHKERTNEGV CEEHHHHHHHCCCCE | 51.08 | 26051181 | |
143 | Ubiquitination | VTYADAHKERTNEGV CEEHHHHHHHCCCCE | 51.08 | 33845483 | |
143 | 2-Hydroxyisobutyrylation | VTYADAHKERTNEGV CEEHHHHHHHCCCCE | 51.08 | - | |
146 | Phosphorylation | ADAHKERTNEGVIEF HHHHHHHCCCCEEEE | 38.42 | 25849741 | |
155 | Phosphorylation | EGVIEFRSYSDMKRA CCEEEEECHHHHHHH | 34.02 | 28555341 | |
157 | Phosphorylation | VIEFRSYSDMKRALD EEEEECHHHHHHHHH | 32.26 | 21815630 | |
160 | Ubiquitination | FRSYSDMKRALDKLD EECHHHHHHHHHHCC | 39.24 | 22817900 | |
160 | 2-Hydroxyisobutyrylation | FRSYSDMKRALDKLD EECHHHHHHHHHHCC | 39.24 | - | |
165 (in isoform 3) | Ubiquitination | - | 49.69 | 21890473 | |
165 | 2-Hydroxyisobutyrylation | DMKRALDKLDGTEIN HHHHHHHHCCCCEEC | 49.69 | - | |
165 | Ubiquitination | DMKRALDKLDGTEIN HHHHHHHHCCCCEEC | 49.69 | 22817900 | |
165 (in isoform 1) | Ubiquitination | - | 49.69 | 21890473 | |
165 | Acetylation | DMKRALDKLDGTEIN HHHHHHHHCCCCEEC | 49.69 | 23954790 | |
169 | Phosphorylation | ALDKLDGTEINGRNI HHHHCCCCEECCEEE | 33.10 | 24719451 | |
182 | 2-Hydroxyisobutyrylation | NIRLIEDKPRTSHRR EEEEECCCCCCCCCC | 24.49 | - | |
182 | Acetylation | NIRLIEDKPRTSHRR EEEEECCCCCCCCCC | 24.49 | 23749302 | |
182 | Sumoylation | NIRLIEDKPRTSHRR EEEEECCCCCCCCCC | 24.49 | 28112733 | |
182 | Ubiquitination | NIRLIEDKPRTSHRR EEEEECCCCCCCCCC | 24.49 | 29967540 | |
185 | Phosphorylation | LIEDKPRTSHRRSYS EECCCCCCCCCCCCC | 37.09 | 24719451 | |
186 | Phosphorylation | IEDKPRTSHRRSYSG ECCCCCCCCCCCCCC | 19.10 | 29449344 | |
190 | Phosphorylation | PRTSHRRSYSGSRSR CCCCCCCCCCCCHHH | 24.49 | 20363803 | |
191 | Phosphorylation | RTSHRRSYSGSRSRS CCCCCCCCCCCHHHH | 18.42 | 20363803 | |
192 | Phosphorylation | TSHRRSYSGSRSRSR CCCCCCCCCCHHHHH | 31.38 | 20363803 | |
194 | Phosphorylation | HRRSYSGSRSRSRSR CCCCCCCCHHHHHHH | 22.57 | 20363803 | |
196 | Phosphorylation | RSYSGSRSRSRSRRR CCCCCCHHHHHHHHH | 35.98 | 20363803 | |
198 | Phosphorylation | YSGSRSRSRSRRRSR CCCCHHHHHHHHHHH | 35.54 | 29449344 | |
204 | Phosphorylation | RSRSRRRSRSRSRRS HHHHHHHHHHHHHHH | 32.56 | 26074081 | |
206 | Phosphorylation | RSRRRSRSRSRRSSR HHHHHHHHHHHHHHH | 35.54 | 26074081 | |
208 | Phosphorylation | RRRSRSRSRRSSRSR HHHHHHHHHHHHHHH | 33.04 | 26074081 | |
216 | Phosphorylation | RRSSRSRSRSISKSR HHHHHHHHHHHHHHH | 31.46 | 24144214 | |
218 | Phosphorylation | SSRSRSRSISKSRSR HHHHHHHHHHHHHHH | 32.24 | 24144214 | |
220 | Phosphorylation | RSRSRSISKSRSRSR HHHHHHHHHHHHHHH | 26.31 | 24719451 | |
222 | Phosphorylation | RSRSISKSRSRSRSR HHHHHHHHHHHHHHH | 28.79 | 24144214 | |
242 | Methylation | RSRSKGRKSRSKSKS CCHHHCCCCCCCCCC | 59.91 | 23748837 | |
253 | Phosphorylation | KSKSKPKSDRGSHSH CCCCCCCCCCCCCCC | 40.86 | 23403867 | |
257 | Phosphorylation | KPKSDRGSHSHSRSR CCCCCCCCCCCCCCC | 23.78 | 27422710 | |
259 | Phosphorylation | KSDRGSHSHSRSRSK CCCCCCCCCCCCCCH | 25.51 | 20068231 | |
261 | Phosphorylation | DRGSHSHSRSRSKDE CCCCCCCCCCCCHHH | 34.66 | 20068231 | |
263 | Phosphorylation | GSHSHSRSRSKDEYE CCCCCCCCCCHHHHH | 43.87 | 26055452 | |
265 | Phosphorylation | HSHSRSRSKDEYEKS CCCCCCCCHHHHHHH | 45.78 | 26055452 | |
269 | Phosphorylation | RSRSKDEYEKSRSRS CCCCHHHHHHHHHHH | 38.50 | 28985074 | |
272 | Phosphorylation | SKDEYEKSRSRSRSR CHHHHHHHHHHHCCC | 24.45 | 25849741 | |
274 | Phosphorylation | DEYEKSRSRSRSRSP HHHHHHHHHHCCCCC | 41.52 | 24719451 | |
278 | Phosphorylation | KSRSRSRSRSPKENG HHHHHHCCCCCCCCC | 38.05 | 24144214 | |
280 | Phosphorylation | RSRSRSRSPKENGKG HHHHCCCCCCCCCCC | 41.38 | 24719451 | |
290 | Acetylation | ENGKGDIKSKSRSRS CCCCCCCCCCCCCCC | 57.48 | 7297899 | |
291 | Phosphorylation | NGKGDIKSKSRSRSQ CCCCCCCCCCCCCCC | 35.88 | 30576142 | |
293 | Phosphorylation | KGDIKSKSRSRSQSR CCCCCCCCCCCCCCC | 42.45 | 20363803 | |
295 | Phosphorylation | DIKSKSRSRSQSRSN CCCCCCCCCCCCCCC | 43.29 | 25159151 | |
297 | Phosphorylation | KSKSRSRSQSRSNSP CCCCCCCCCCCCCCC | 33.48 | 25159151 | |
299 | Phosphorylation | KSRSRSQSRSNSPLP CCCCCCCCCCCCCCC | 38.63 | 30278072 | |
301 | Phosphorylation | RSRSQSRSNSPLPVP CCCCCCCCCCCCCCC | 47.08 | 29255136 | |
303 | Phosphorylation | RSQSRSNSPLPVPPS CCCCCCCCCCCCCHH | 29.12 | 19664994 | |
303 (in isoform 3) | Phosphorylation | - | 29.12 | 29743597 | |
310 | Phosphorylation | SPLPVPPSKARSVSP CCCCCCHHHHCCCCC | 32.64 | 23927012 | |
314 | Phosphorylation | VPPSKARSVSPPPKR CCHHHHCCCCCCCCC | 31.63 | 22167270 | |
316 | Phosphorylation | PSKARSVSPPPKRAT HHHHCCCCCCCCCCC | 32.70 | 22167270 | |
323 | Phosphorylation | SPPPKRATSRSRSRS CCCCCCCCCHHHHHH | 28.80 | 20068231 | |
324 | Phosphorylation | PPPKRATSRSRSRSR CCCCCCCCHHHHHHH | 27.55 | 20068231 | |
326 | Phosphorylation | PKRATSRSRSRSRSK CCCCCCHHHHHHHHH | 34.08 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
303 | S | Phosphorylation | Kinase | DYRK1A | Q13627 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SRSF6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SRSF6_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RNPS1_HUMAN | RNPS1 | physical | 16189514 | |
A4_HUMAN | APP | physical | 21832049 | |
SF3B4_HUMAN | SF3B4 | physical | 22365833 | |
RBM10_HUMAN | RBM10 | physical | 22365833 | |
TRA2B_HUMAN | TRA2B | physical | 22365833 | |
TOE1_HUMAN | TOE1 | physical | 22365833 | |
RL24_HUMAN | RPL24 | physical | 22863883 | |
LC7L2_HUMAN | LUC7L2 | physical | 25416956 | |
ATLA3_HUMAN | ATL3 | physical | 26344197 | |
RBBP4_HUMAN | RBBP4 | physical | 26344197 | |
RNPS1_HUMAN | RNPS1 | physical | 26344197 | |
SRSF1_HUMAN | SRSF1 | physical | 26344197 | |
TRA2A_HUMAN | TRA2A | physical | 26344197 | |
TRA2B_HUMAN | TRA2B | physical | 26344197 | |
SRSF3_HUMAN | SRSF3 | physical | 27173435 | |
PR38A_HUMAN | PRPF38A | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-101, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-303, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301; SER-303; SER-314AND SER-316, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-297; SER-299; SER-303;SER-314 AND SER-316, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303; SER-314 ANDSER-316, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-259; SER-297;SER-299; SER-301; SER-303; SER-314 AND SER-316, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301; SER-314 ANDSER-316, AND MASS SPECTROMETRY. |